The Global Biopharmaceutical Glass Packaging Market was valued at USD 9.86 Billion in 2025 and is projected to reach USD 15.72 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period. This growth is being driven by rising demand for biologics and injectable drugs, stringent regulatory requirements for drug safety and sterility, and increasing vaccine production worldwide.

As the biopharmaceutical industry advances with complex biologics, monoclonal antibodies, and next-generation therapies, the spotlight is on the key glass packaging suppliers who are driving innovation, product stability, and reliable delivery solutions. In this blog, we profile the Top 10 Companies in the Biopharmaceutical Glass Packaging Market—a mix of specialty glass manufacturers, technology innovators, and global suppliers shaping the future of safe and effective pharmaceutical containment.

---

🔟 1. SCHOTT AG

Headquarters: Mainz, Germany
Key Offering: Borosilicate glass vials, ampoules, cartridges, and prefilled syringes

SCHOTT AG is a global leader in pharmaceutical glass packaging, known for its high-quality Type I borosilicate glass solutions that ensure chemical inertness and long-term drug stability. The company serves major biopharmaceutical manufacturers with advanced containment systems designed for sensitive biologics and vaccines.

Innovation Initiatives:

• Development of chemically strengthened glass technologies

• Investments in capacity expansion for North America and Europe

• Focus on delamination-resistant and coated glass solutions

Download FREE Sample Report: Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

---

9️⃣ 2. Gerresheimer AG

Headquarters: Düsseldorf, Germany
Key Offering: Glass vials, ampoules, cartridges, and specialty packaging systems

Gerresheimer AG is a prominent supplier of primary packaging for the pharmaceutical and biopharmaceutical industries. The company provides a wide range of glass containers with emphasis on precision manufacturing and compliance with stringent regulatory standards.

Innovation Initiatives:

• Expansion of production facilities for biologics packaging

• Development of sustainable and lightweight glass formats

• Integration of digital quality control systems

---

8️⃣ 3. Corning Incorporated

Headquarters: Corning, New York, USA
Key Offering: Valor® Glass vials and advanced pharmaceutical glass solutions

Corning Incorporated brings materials science expertise to biopharmaceutical packaging with its innovative Valor Glass technology, which offers improved strength, reduced breakage, and lower particulate generation compared to conventional glass.

Innovation Initiatives:

• Proprietary glass strengthening processes

• Partnerships with leading biopharma companies for custom solutions

• Focus on enhancing drug stability and manufacturing efficiency

---

7️⃣ 4. Nipro Corporation

Headquarters: Osaka, Japan
Key Offering: Glass vials, ampoules, prefillable syringes, and cartridges

Nipro Corporation is a major player in Asia with a strong global presence, supplying high-quality glass packaging solutions tailored for injectable drugs and biologics. The company emphasizes cost-effective production while meeting international quality standards.

Innovation Initiatives:

• Capacity expansions to support vaccine and biosimilar demand

• Development of integrated syringe systems

• Advancements in siliconization and surface treatment technologies

Download FREE Sample Report: Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

---

6️⃣ 5. Stevanato Group S.p.A.

Headquarters: Piombino Dese, Italy
Key Offering: Glass containers, prefilled syringes, and integrated drug delivery systems

Stevanato Group specializes in end-to-end solutions for biopharmaceutical packaging, combining glass forming expertise with assembly and filling technologies to support complex drug delivery needs.

Innovation Initiatives:

• Vertically integrated manufacturing capabilities

• Focus on ready-to-use sterile containers

• Investments in automation for higher precision

---

5️⃣ 6. SGD Pharma

Headquarters: Paris, France
Key Offering: Molded and tubular glass vials, bottles, and ampoules

SGD Pharma delivers pharmaceutical-grade glass packaging with a focus on molded glass technologies suitable for a variety of liquid and lyophilized formulations used in biopharmaceutical applications.

Innovation Initiatives:

• Enhancements in glass durability and chemical resistance

• Expansion of sterile packaging offerings

• Commitment to sustainable manufacturing practices

---

4️⃣ 7. West Pharmaceutical Services, Inc.

Headquarters: Exton, Pennsylvania, USA
Key Offering: Glass vials with elastomeric closures and containment systems

West Pharmaceutical Services provides integrated packaging and delivery solutions, combining high-quality glass components with advanced closure technologies essential for maintaining sterility in biopharmaceutical products.

Innovation Initiatives:

• Development of novel container-closure systems

• Support for high-potency and sensitive drug formulations

• Global supply chain optimization for critical medicines

---

3️⃣ 8. Becton, Dickinson and Company (BD)

Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: Glass prefillable syringes and injection systems

BD is recognized for its expertise in drug delivery devices, offering glass-based prefillable syringes that improve dosing accuracy and patient safety for injectable biopharmaceuticals.

Innovation Initiatives:

• Advancements in silicone-free and low-particle syringe technologies

• Expansion of manufacturing for autoinjector-compatible formats

• Collaboration with biopharma firms on combination products

Download FREE Sample Report: Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

---

2️⃣ 9. Shandong Pharmaceutical Glass Co., Ltd.

Headquarters: Zibo, China
Key Offering: Tubular glass vials, ampoules, and pharmaceutical bottles

Shandong Pharmaceutical Glass has grown rapidly as a key supplier, particularly in Asia, providing cost-competitive yet high-standard glass packaging that meets growing demand for biologics and generics.

Innovation Initiatives:

• Upgrades to meet international GMP and quality standards

• Increased export focus to emerging pharmaceutical markets

• Investments in modern production lines for borosilicate glass

---

1️⃣ 10. Ardagh Group S.A.

Headquarters: Luxembourg, Luxembourg
Key Offering: Glass packaging solutions for pharmaceutical applications

Ardagh Group brings extensive glass manufacturing experience to the biopharmaceutical sector, supplying containers that support stable storage and transport of injectable and parenteral medications.

Innovation Initiatives:

• Development of lightweight and sustainable glass options

• Strategic focus on pharmaceutical-grade quality control

• Expansion of specialty formats for biologics

Read Full Report: Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Biopharmaceutical Glass Packaging Is Stronger and More Innovative

The biopharmaceutical glass packaging market is undergoing significant evolution. While traditional borosilicate glass continues to dominate due to its unmatched chemical inertness and barrier properties, the industry is investing in advanced surface treatments, strengthened formulations, and improved manufacturing processes to address challenges like delamination and breakage.

📈 Key Trends Shaping the Market:

• Rising adoption of prefilled syringes and ready-to-use containers for patient convenience

• Regulatory emphasis on extractables and leachables testing favoring high-quality glass

• Capacity expansions and technology upgrades to meet biologics and vaccine demand

• Growing focus on sustainability through lightweighting and recycling initiatives

Read Full Report: Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

The companies listed above are not only providing essential containment solutions—they are enabling the safe delivery of life-changing biopharmaceutical therapies to patients around the world.